Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| NGP Energy Capital Management, L.L.C. | PR Permian Resources Corp | 13D/A | 5.7% | Mar 6, 2024 | 2y |
| August J. Troendle | MEDP Medpace Holdings, Inc. | 13D/A | 19.4% | Mar 6, 2024 | 2y |
| Spectrum Equity VII, L.P. | GDRX GoodRx Holdings, Inc. | 13D/A | 24.3% | Mar 6, 2024 | 2y |
| NSV Investments I, L.P. | VTYX Ventyx Biosciences, Inc. Common Stock | 13D/A | 14.2% | Mar 6, 2024 | 2y |
| Saba Capital Management, L.P. | ECAT BlackRock ESG Capital Allocation Term Trust | 13D/A | 27.05% | Mar 6, 2024 | 2y |
| Francisco Partners IV, L.P. | GDRX GoodRx Holdings, Inc. | 13D/A | 42.9% | Mar 6, 2024 | 2y |
| ROBOTTI ROBERT | TDW Tidewater Inc | 13D/A | 6.5% | Mar 5, 2024 | 2y |
| Charles Frischer | NN Nextnav Inc. | 13D | 5.3% | Mar 5, 2024 | 2y |
| GIC Private Ltd | CGNX Cognex Corp | 13G | 5.04% | Mar 5, 2024 | 2y |
| Laura E. Niklason | HUMA Humacyte, Inc. | 13D/A | 8.4% | Mar 5, 2024 | 2y |
| JANUS HENDERSON GROUP PLC | APLT Applied Therapeutics, Inc. Common Stock | 13G | 6.1% | Mar 1, 2024 | 2y |
| NEUBERGER BERMAN GROUP LLC | UFPT Ufp Technologies Inc | 13G/A | 10% | Feb 29, 2024 | 2y |
| Wealthspring Capital LLC | ESHA ESH Acquisition Corp. | 13G | 10.8% | Feb 29, 2024 | 2y |
| Capital World Investors | MOS Mosaic Co | 13G/A | 6.1% | Feb 29, 2024 | 2y |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | NRC Nrc Health | 13G/A | 13.38% | Feb 29, 2024 | 2y |
| Mawer Investment Management Ltd. | NOA North American Construction Group Ltd. | 13G/A | 10.42% | Feb 29, 2024 | 2y |
| Wealthspring Capital LLC | ANSC Agriculture & Natural Solutions Acquisition Corp | 13G | 10.2% | Feb 29, 2024 | 2y |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | NBXG Neuberger Next Generation Connectivity Fund Inc. | 13G/A | 5% | Feb 29, 2024 | 2y |
| Capital World Investors | LUV Southwest Airlines Co | 13G/A | 10% | Feb 29, 2024 | 2y |
| Capital World Investors | RRX Regal Rexnord Corp | 13G/A | 10% | Feb 29, 2024 | 2y |
| NEUBERGER BERMAN GROUP LLC | PLCE Childrens Place, Inc. | 13G/A | 0.16% | Feb 29, 2024 | 2y |
| Dodge & Cox | IFF International Flavors & Fragrances Inc | 13G/A | 10.6% | Feb 29, 2024 | 2y |
| Wealthspring Capital LLC | AFJK Aimei Health Technology Co., Ltd. | 13G | 13.3% | Feb 29, 2024 | 2y |
| Capital Research Global Investors | PNW Pinnacle West Capital Corp | 13G/A | 11.2% | Feb 29, 2024 | 2y |
| Lindsell Train Ltd | MANU Manchester United plc | 13G/A | 15.13% | Feb 29, 2024 | 2y |
| Newtyn Management, LLC | MDRX Veradigm Inc. Common Stock | 13G | 9.6% | Feb 28, 2024 | 2y |
| Deep Track Capital, LP | PYXS Pyxis Oncology, Inc. | 13G | 7.87% | Feb 27, 2024 | 2y |
| Foxhaven Asset Management, LP | CARG CarGurus, Inc. | 13G | 5.5% | Feb 27, 2024 | 2y |
| Blufire Capital Limited | EVE EVe Mobility Acquisition Corp | 13D | 40.5% | Feb 26, 2024 | 2y |
| Rosenthal Lee | FNA Paragon 28, Inc. | 13G/A | 8.8% | Dec 31, 2023 | 2y |
| HealthCap VII, L.P. | CARM Carisma Therapeutics Inc. | 13D/A | 8.4% | Mar 7, 2024 | 2y |
| QVT Financial LP | ROIV Roivant Sciences Ltd. | 13G/A | 8.28% | Mar 7, 2024 | 2y |
| GENERAL ATLANTIC, L.P. | IMCR Immunocore Holdings plc | 13D/A | 3.5% | Mar 7, 2024 | 2y |
| Great Hill Equity Partners IV, L.P. | INTA Intapp, Inc. | 13D/A | 9.2% | Mar 7, 2024 | 2y |
| HealthCap VIII, L.P. | SPRB Spruce Biosciences, Inc. | 13D/A | 8.9% | Mar 7, 2024 | 2y |
| HealthCap VII, L.P. | FUSN Fusion Pharmaceuticals Inc. Common Shares | 13D/A | 5.3% | Mar 7, 2024 | 2y |
| Point72 Asset Management, L.P. | TERN Terns Pharmaceuticals, Inc. | 13G | 6.3% | Mar 6, 2024 | 2y |
| G. Troy Meier | SDPI Superior Drilling Products Inc. | 13D/A | 38.1% | Mar 6, 2024 | 2y |
| Daqing Mao | UK Ucommune International Ltd | 13D | 17.2% | Mar 6, 2024 | 2y |
| 22NW Fund, LP | FARM FARMER BROTHERS CO | 13D/A | 9.3% | Mar 6, 2024 | 2y |
| Karpus Management, Inc. | EIM Eaton Vance Municipal Bond Fund | 13D/A | 20.03% | Mar 6, 2024 | 2y |
| JCP Investment Management, LLC | FARM FARMER BROTHERS CO | 13D/A | 4.7% | Mar 6, 2024 | 2y |
| Fresenius Medical Care Holdings, Inc. | HUMA Humacyte, Inc. | 13D/A | 15.4% | Mar 5, 2024 | 2y |
| Maritime Investors Corp. | PXS Pyxis Tankers Inc. | 13D/A | 54.8% | Mar 5, 2024 | 2y |
| Gold Fields Limited | GAU Galiano Gold Inc. | 13D/A | 19.9% | Mar 5, 2024 | 2y |
| JAB BevCo B.V. | KDP Keurig Dr Pepper Inc. | 13D/A | 23.9% | Mar 5, 2024 | 2y |
| HELU CARLOS SLIM | TALO Talos Energy Inc. | 13G | 18.9% | Mar 5, 2024 | 2y |
| BCPE Watson (DE) BML, LP | COHR Coherent Corp. | 13D/A | 15.6% | Mar 5, 2024 | 2y |
| THOMPSON DAVIS & CO., INC. | SMID Smith Midland Corp | 13D/A | 28.54% | Mar 5, 2024 | 2y |
| NOVO HOLDINGS A/S | LVTX LAVA Therapeutics N.V. Ordinary Shares | 13D/A | 0% | Mar 5, 2024 | 2y |